Breaking News

Long road ahead for the new fully sequenced genome; the race to host high-stakes research agency

 

Daily Recap

STAT+: For patients, seeing the benefits of the new, fully sequenced genome could take years

By Megan Molteni

Adobe

It will take time for DNA analysis pipelines to spit out data that is reliable enough that doctors and patients can use it to make decisions.

Read More

STAT+: Biden's new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on

By Lev Facher

Alex Hogan/STAT

Cities and states are jockeying to become the official home of ARPA-H, Biden’s new life science research agency.

Read More

STAT+: Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules

By Nicholas Florko

TOM WILLIAMS/POOL/AFP via Getty Images

A bipartisan duo of senators is done waiting for the FDA to finalize a rule that will let companies sell hearing aids over the counter.

Read More

Opinion: Medicare got it right: Unproven Alzheimer's drug would have threatened the financial stability of 60 million Americans

By John N. Mafi and Catherine Sarkisian

Adobe

Covering the use of Aduhelm for millions of Americans with Alzheimer's would have accelerated Medicare's path toward bankruptcy.

Read More

Friday, April 8, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments